Triage. The state of the systems.
You already know this part. We're writing it down anyway, because somehow it's still controversial to say out loud.
In the United States, you can have insurance, a primary-care doctor, a wearable on your wrist, and still wait three weeks for a fifteen-minute visit. In the United Kingdom, you can phone the surgery at 8 a.m. and not get through. In Canada, you can wait six months for an MRI a friend in Mexico got the same week. In France and Germany, primary-care visits are quick - and the moment you need a specialist, the queues lengthen and the certainty fades. The systems are different. The experience is the same.
Most people do not start with complete context. They start with whatever they can reach - a portal, a lab result, a search page, a family note, a wearable trend. The clinic is often the second step. The first step is trying to understand what is happening well enough to ask for the right help. That first step should not be a guess.
The people inside the system are leaving it. Burnout among physicians sits above half in every major market we've looked at. Nursing strikes are at decade highs. Junior doctors quit before they finish. The buildings stay open. The shortages get longer. The waits get longer. The fifteen-minute visit gets shorter.
And underneath all of it: a person who is sick or worried, scrolling.
The most expensive systems on Earth, and the average person's first move is still a guess.
Context. Why people feel stuck.
Three failures, stacked. Not unique to one country. Stacked everywhere we've looked. Together, they create the opening for a different kind of product.
1. The expertise wall.
The science of medicine is, mostly, public. Guidelines, reference ranges, drug labels, screening intervals - published, indexed, freely available. The translation isn't. Reading a guideline is not the same as understanding what to do with it. The wall isn't paper, it's synthesis. And the synthesis is rationed by people in fifteen-minute increments. That's the wall.
2. The middleman tax.
Most healthcare systems put a third party - an insurer, a government scheme, an HMO, a clinic-owned negotiator - between you and the care you're receiving. The buyer and the user are different people. When that happens, the product stops competing on what the user would actually pay for. Pricing goes opaque. Quality drifts. Bills arrive months later for care you can no longer evaluate. Wait times become the rationing mechanism instead of price. The shape changes country by country. The dynamic is the same.
3. The averaging problem.
Modern medicine is, statistically, designed for an average that no patient actually is. Reference ranges are population means. Drug dosing is a coarse split across metabolizer phenotypes. Screening guidelines are written for cohorts and re-fit to you with a stopwatch running. Your wearable patterns, your own labs over time, your family history, your real day - invisible inside a fifteen-minute visit. The bottleneck isn't collection. Your phone and watch already have it. The bottleneck is someone, or something, paying attention to you, longitudinally.
An expertise wall. A middleman tax. A patient of one, treated as an average.
Prognosis. A different way to think about it.
The systems we have are reactive. You feel something. You try to find someone. You wait. You explain. You wait again. You react.
The product we want, the one most people would design if they were starting today, keeps continuity between those moments. It knows what information is available, what changed, what is missing, and what deserves a next step. It treats you as a sample of one, not a slice of a million. That has not existed at consumer scale.
That product supports care instead of pretending to be care. It helps you walk into the visit with useful context and walk out understanding what was said. The clinician gets a better-briefed patient. The patient gets fewer unanswered first questions.
Laymen is our attempt at that missing layer. Three parts, one through-line: information about your body should be understandable, connected, and useful when you need it.
Layer 01 - Terms. Free, forever.
Plain-English health answers, with sources, available to anyone with a browser. The literal translation of “in laymen's terms.” The front door of health context, finally open without a referral. Not behind insurance. Not behind a visit. Not behind expertise. Just the first read.
Layer 02 - Baseline. Your private health layer.
Daily Guidance from your Health State: what matters today, why it matters, what is missing, and what to do next. Baseline connects labs, wearables, medications, history, and context over time, only for you. This is the core bet: health guidance should have memory.
Layer 03 - Genome. The lifelong foundation.
A planned genetic context layer for Baseline, built around privacy, consent, and review. When it is ready, Genome should help add evidence-backed context where genetics can responsibly inform the picture. The long-term Health State should get more personal, not more noisy.
Reactive systems wait for a visit. We're building the health layer that keeps paying attention between them.
Why no insurance.
We don't take it. Not now, not later. The systems are broken specifically because they severed the buyer from the user. We're reconnecting them. You pay, you choose, you care about the outcome - so the product has to. In return, we charge less than a single specialist visit a year, and keep it that way.
Where this ends.
It ends with more people feeling prepared before care and less confused after it. Sleep that's honestly tracked. Medications you actually understand. A lab panel you can read. A clinician visit that starts at minute three instead of minute fifteen. A health system that finally has continuity on the user's side.
We're not promising medical certainty or longevity science you cannot verify. We're building tools - clear, private, longitudinal - that help you understand your health signals and follow through. It is ambitious because it has to be. That's the prognosis.
The job in front of us is large. The job behind us, larger.
We're going.